Immunological Mechanisms Underneath the Efficacy of Cancer Therapy.
about
Diagnosis and treatment of epidural metastasesDiagnosis and treatment of epidural metastases.Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future.Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors.Conditioning neoadjuvant therapies for improved immunotherapy of cancer.Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.Trial watch: Immune checkpoint blockers for cancer therapy.Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.Immune recognition of irradiated cancer cells.Role of immune-checkpoint inhibitors in lung cancer.Perturbing mitosis for anti-cancer therapy: is cell death the only answer?Trial Watch: Adoptively transferred cells for anticancer immunotherapy.Current landscape of immunotherapy for the treatment of metastatic non-small-cell lung cancer.Naturally-Occurring Canine Invasive Urothelial Carcinoma: A Model for Emerging Therapies.Locally-advanced non-small cell lung cancer: shall immunotherapy be a new chance?Shining light on advanced NSCLC in 2017: combining immune checkpoint inhibitors.Trial watch: Immunogenic cell death induction by anticancer chemotherapeuticsTrial watch: DNA-based vaccines for oncological indicationsPresent and future of cancer immunotherapy: A tumor microenvironmental perspectiveNaturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer
P2860
Q28586295-8FD2D51C-E254-4398-942D-CF5E6E92A16AQ30239912-9EEE2C27-B670-4718-86F9-1AF90EDFBE15Q38687631-37B2788E-A612-4323-909A-066FB56E881FQ41593373-A0DE883E-2A2F-4494-ACC9-8B07F8B710E4Q45065285-E7BD3F63-A539-49B5-8DC2-71BDD882DA4BQ47325431-C7698A1F-F2BA-45C7-BF78-2249E22901C2Q47350013-08D30999-73F2-4B29-A02F-0486F6D0BB32Q47393365-21C33BC7-9B28-4B66-8B71-FB2ED5616806Q47843948-CA3D156E-07DB-4A73-A201-CDEE28F7833DQ48193633-B6B9A9E4-6240-4952-A996-F81E74121009Q49549096-D1DF86F7-2A68-48CC-B3CC-F005FA82627BQ49832249-755DFB46-DA8C-458E-9D28-875263C041A2Q52780137-4180D5CD-A1FB-4206-B407-269451838517Q55077977-F8FA7B67-7E37-4C14-8EB2-FCABDD9C2F74Q55081994-94E74C22-AA12-4830-9DC8-07648073A935Q55286402-8AC08532-524C-417D-9C8B-D8BEF4269558Q55288740-4EF60ECC-8780-4D0A-8E33-8AC5ACDA5CCAQ56594845-00D59D0A-88F6-41B5-994F-A58B68423059Q56893452-A7B0418C-C154-42E8-8949-DEE37E59F2C9Q57144510-58B360C3-070E-4D1D-956B-674686EB941EQ58795373-A7071305-8205-4526-A9D8-4AE121B7647A
P2860
Immunological Mechanisms Underneath the Efficacy of Cancer Therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Immunological Mechanisms Underneath the Efficacy of Cancer Therapy.
@en
type
label
Immunological Mechanisms Underneath the Efficacy of Cancer Therapy.
@en
prefLabel
Immunological Mechanisms Underneath the Efficacy of Cancer Therapy.
@en
P50
P1476
Immunological Mechanisms Underneath the Efficacy of Cancer Therapy.
@en
P304
P356
10.1158/2326-6066.CIR-16-0197
P577
2016-11-01T00:00:00Z